Geneseq Accession No: R93087 (Aug. 27, 1996).* |
Geneseq Accession No: W22670 (Mar. 19, 1998).* |
Geneseq Accession No: W30191 (May 21, 1998).* |
Geneseq Accession No: W56087 (Aug. 17, 1998).* |
Geneseq Accession No: W56690 (Jul. 23, 1998).* |
Geneseq Accession No: W57475 (Sep. 7, 1998).* |
Geneseq Accession No: W44398 (Jun. 11, 1998).* |
Geneseq Accession No: W61279 (Sep. 24, 1998).* |
Geneseq Accession No: T90880 (May 21, 1998).* |
Geneseq Accession No: V28591 (Aug. 17, 1998).* |
Geneseq Accession No: W17660 (Dec. 16, 1997).* |
Geneseq Accession No: R95690 (Dec. 20, 1996).* |
Geneseq Accession No: T90883 (May 21, 1998).* |
GenBank Accession No: U77035 (Jan. 23, 1997).* |
GenBank Accession No: D86955 (Mar. 6, 1997).* |
GenBank Accession No: U64197 (Jun. 25, 1997).* |
GenBank Accession No: I35613 (Feb. 26, 1997).* |
GenBank Accession No: U46767 (Dec. 14, 1996).* |
GenBank Accession No: X98306 (Jul. 20, 1998).* |
Hieshima, K., et al., J. Immunol., vol. 159:1140-9 (1997).* |
Kodelja, V., et al., The J. Immunology, vol. 160:1411-1418 (1998).* |
Patel, V. P., et al., J. Exp. Med., vol. 185:1163-1172 (1997).* |
Taub, D. D. et al., Therapeutic Immunology vol. 1:229-246 (1994).* |
George et al., Macromolecular Sequencing & Synthesis, Ch. 12:127-149 (1988).* |
Berger, M. S. et al., Clinical Research, vol. 42:305A (1994).* |
Uguccioni, M. et al., J. Exp. Med., vol. 183-2379-2384 (1996).* |
Craddock et al., Blood, vol. 90:4779-4788 (1997).* |
Liu et al., Blood, vol. 90:2522-2528 (1997).* |
Laterveer et al., Blood, vol. 87-781-788 (1966).* |
Laterveer et al., Exp. Hematology, vol. 24:1387-1393 (1996).* |
Blum, S. et al., DNA and Cell Biology, vol. 9:589-602 (1990).* |
Obaru, K., et al., J. Biochem., vol. 99:885-894 (1986).* |
Derynck, R., et al., Biochemestry, vol. 29:10225-10233 (1990).* |
Sudo, K. et al., Genomics, vol. 24:276-276 (1994).* |
Lukacs, N. W., et al., J. Exp. Med., vol. 177:1551-1559 (1993).* |
Jose, P. J. et al., J. Exp. Med. vol. 179:881-887 (1994).* |
Kuna, P. et al., The J. of Exp. Med. vol. 174:489-493 (1992).* |
Matsushima, K. et al., The J. of Exp. Med. vol. 169:1485-1490 (1989).* |
Schall, T. J. et al., Cytokine, vol 3:165-183 (1991).* |
Clements J. M., et al., Cytokine, vol. 4:72-82 (1992).* |
Zipfel, P. F., et al., The J. of Immunology, vol. 142:1582-1590 (1989).* |
Graham, G. J. et al., Development Biology, vol. 151:377-381 (1992).* |
Bioschoff, S. C., et al., J. Exp. Med., vol. 175:1271-1275 (1992).* |
Lerner, R. A. et al., Nature, vol. 299 (1982).* |
Nakao, M. et al., Molecular and Cellular Biology, vol. 10:3646-3658 (1990).* |
Kwon, Y. S. et al., Proc. Natl. Acad. Sci., vol. 86:1963-1967 (1989).* |
Widmer, U. et al., J. Immunolgoy, vol. 150:4996-5012 (1993).* |
Schall, T. et al., J. Imm. vol. 22:1477-1481 (1992).* |
Furuta, R. et al., J. Biochem., vol. 106:436-441 (1989).* |
Brown, et al., J. Immunology, vol. 142:679-687 (1989).* |
Kurdowska, A., et al., Cytokine, vol. 6:124-134 (1994).* |
International Search Report, EP 97 30 3204 (Jan. 23, 1998).* |
Craddock et al., “Antibodies to VLA4 Integrin Mobilize Long-Term Repopulating Cells and Augment Cytokine-Induced Mobilization in Primates and Mice”, Blood, 90(12), pp. 4779-47988 (1997).* |
Liu et al., “The Granulocyte Colong-Stimulating Factor Receptor Is Required for the Mobilzation of Murine Hematopoietic Progenitors Into Peripheral Blood by Cyclophosphamide or Interleukin-8 but Not Flt-3 Ligand”, Blood, 90(7), pp. 2522-2528 (1997).* |
Laterveer et al., “Rapid Moblization of Hematopoietic Progenitor Cells In Rhesus Monkeys by a Single Intravenous Injection of Interleukin-8”, Blood, 87(2), pp. 781-788 (1996).* |
Laterveer et al., “Improved Survival of Lethally Irradiated Recipient Mice Transplanted With Circulating Progenitor Cells Mobilized by IL-8 After Pretreatment with Stem Cell Factor”, Experimental Hematology, 24, pp.137-1393 (1996). |